Clinical Trial Update: The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Androxal to AndroGel for morning testosterone in men with secondary hypogonadism; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• ANDROGEL (Testosterone)
• Androxal (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2015-09-23